The scope of interventional cardiology has rapidly expanded over the last several decades.In a field where procedural treatment options for a variety of complex
Introduction There is now a new way to treat hypercholesterolemia,using a monoclonal antibody(Evolocumab)that binds to and inhibits PCSKA9.Most physicians know